iShares U.S. Pharmaceuticals ETF

1. 01

   0.3% below its 52-week high

   Closed at $109.09 on 4 Nov 2026: 0.3% below the 52-week high of $109.43 (30 Oct 2026) and 45.4% above the low of $75.03 (7 Nov 2025).

   Daily price bars, split-adjusted · as of 4 Nov 2026

2. 02

   Ahead of SPY over 1 year

   1 month: +10.9% (SPY −1.6%). 3 months: +6.5% (SPY −0.4%). 1 year: +43.6% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: IHE, SPY · as of 4 Nov 2026

3. 03

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $109.09 was 6.5% above its 50-day average ($102.45) and 14.7% above its 200-day average ($95.09). It has closed above the 200-day for 310 sessions, since 13 Aug 2025. The 50-day average crossed above the 200-day on 27 Aug 2025, 299 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

4. 04

   Short interest at 1.8% of shares outstanding

   266.3K shares were sold short at the 15 Oct 2026 settlement, 1.8% of the 15.0M shares outstanding; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

At the 4 Nov 2026 close